EX-99.1 2 ea020899801ex99-1_ellomay.htm PRESS RELEASE: "ELLOMAY CAPITAL REPORTS RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2024," AS AMENDED

Exhibit 99.1

 

 

Ellomay Capital Reports Results for the Three Months Ended March 31, 2024

 

Tel-Aviv, Israel, June 30, 2024 – Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited financial results for the three month period ended March 31, 2024.

 

Financial Highlights

 

Total assets as of March 31, 2024 amounted to approximately €666.8 million, compared to total assets as of December 31, 2023 of approximately €612.9 million.

 

Revenues1 for the three months ended March 31, 2024 were approximately €8.2 million, compared to revenues of approximately €11.7 million for the three months ended March 31, 2023.

 

Loss from continuing operations for the three months ended March 31, 2024 was approximately €4.6 million, compared to net profit from continuing operations of approximately €3 million for the three months ended March 31, 2023. Loss for the three months ended March 31, 2024 was approximately €4.9 million, compared to net profit of approximately €3.3 million for the three months ended March 31, 2023.

 

EBITDA for the three months ended March 31, 2024 was approximately €1.6 million, compared to EBITDA of approximately €4.2 million for the three months ended March 31, 2023. See below under “Use of Non-IFRS Financial Measures” for additional disclosure concerning EBITDA.

 

On December 31, 2023, the Company executed an agreement to sell its holdings in the 9 MW solar plant located in Talmei Yosef. The sale was consummated following the balance sheet date, on June 3, 2024, and the net consideration received at closing was approximately NIS 42.6 million (approximately €10.6 million). In connection with the expected sale, the Company presents the results of this solar plant as a discontinued operation and the results for the three months ended March 31, 2023 were adjusted accordingly.

 

Financial Overview for the Three Months Ended March 31, 2024

 

Revenues were approximately €8.2 million for the three months ended March 31, 2024, compared to approximately €11.7 million for the three months ended March 31, 2023. The decrease in revenues mainly results from the decrease in electricity prices in Spain.

 

Operating expenses were approximately €4.6 million for the three months ended March 31, 2024, compared to approximately €6.4 million for the three months ended March 31, 2023. The decrease in operating expenses mainly results from a decrease in direct taxes on turnover paid by the Company’s Spanish subsidiaries as a result of reduced electricity prices. The operating expenses of the Company’s Spanish subsidiaries for the three months ended March 31, 2023 were impacted by the Spanish RDL 17/2022, which established the reduction of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases, accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. Depreciation and amortization expenses were approximately €4.1 million for the three months ended March 31, 2024, compared to approximately €4 million for the three months ended March 31, 2023.

 

 

1The revenues presented in the Company’s financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company’s investor presentation.

 

 

 

 

Project development costs were approximately €1.4 million for the three months ended March 31, 2024, compared to approximately €1.2 million for the three months ended March 31, 2023. The increase in project development costs is mainly due to development expenses in connection with solar projects in the USA, Italy, and Israel.

 

General and administrative expenses were approximately €1.6 million for the three months ended March 31, 2024, compared to approximately €1.4 million for the three months ended March 31, 2023. The increase in general and administrative expenses is mostly due to higher consultancy expenses.

 

The Company’s share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €1.3 million for the three months ended March 31, 2024, compared to approximately €1.2 million for the three months ended March 31, 2023. The increase in share of profits of equity accounted investee was mainly due to lower financing expenses incurred by Dorad for the period as a result of the CPI indexation of loans from banks.

 

Financing expenses, net, were approximately €3.3 million for the three months ended March 31, 2024, compared to financing income of approximately €1.7 million for the three months ended March 31, 2023. The increase in financing expenses, net, was mainly attributable to expenses resulting from exchange rate differences amounted to approximately €0.5 million for the three months ended March 31, 2024, compared to income resulting from exchange rate differences of approximately €4.4 million for the three months ended March 31, 2023, an aggregate change of approximately €5.1 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures and were caused by the 0.8% appreciation of the NIS against the euro during the three months ended March 31, 2024, compared to a 4.8% devaluation of the NIS against the euro during the three months ended March 31, 2023. The increase in financing expenses was partially offset by an increase in financing income of approximately €0.5 million in connection with derivatives and warrants in the three months ended March 31, 2024, compared to the three months ended March 31, 2023.

 

Tax benefit was approximately €0.8 million for the three months ended March 31, 2024, compared to taxes on income of approximately €1.4 million in three months ended March 31, 2023. The change in tax is mainly due to deferred tax recorded in connection with carry forward loss for which deferred tax were not previously recorded, partially offset by the decrease in electricity prices in Spain, resulting in lower taxable income of the Company’s Spanish subsidiaries.

 

Loss from discontinued operation (net of tax) was approximately €0.3 million for the three months ended March 31, 2024, compared to a profit from discontinued operation of approximately €0.2 million for the three months ended March 31, 2023.

 

2

 

 

Loss for the three months ended March 31, 2024 was approximately €4.9 million, compared to net profit of approximately €3.3 million for the three months ended March 31, 2023.

 

Total other comprehensive income was approximately €12 million for three months ended March 31, 2024, compared to total other comprehensive loss of approximately €26.6 million in three months ended March 31, 2023. The change in total other comprehensive loss mainly results from changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the “Talasol PPA”). The Talasol PPA experienced a high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows.

 

Total comprehensive income was approximately €7.1 million for the three months ended March 31, 2024, compared to total comprehensive loss of approximately €29.9 million for the three months ended March 31, 2023.

 

EBITDA was approximately €1.6 million for the three months ended March 31, 2024, compared to approximately €4.2 million for the three months ended March 31, 2023.

 

Net cash from operating activities was approximately €1.2 million for the three months ended March 31, 2024, compared to approximately €1.8 million for the three months ended March 31, 2023.

 

On January 16, 2024, the Company issued in an Israeli public offering units consisting of an aggregate principal amount of NIS 170 million of its newly issued Series F Debentures, due March 31, 2030, and the Series 2 Options to purchase an aggregate of 1,020,000 ordinary shares at a price per share of NIS 80 (subject to customary adjustments), which expire on January 5, 2028. The net proceeds of the offering, net of related expenses such as consultancy fee and commissions, were approximately NIS 165 million (approximately €40 million as of the issuance date).

 

On April 17, 2024, the Company issued NIS 40 million par value of the Series F Debentures in a private placement to Israeli classified investors for an aggregate gross consideration of approximately NIS 37.8 million (approximately €9.4 million as of the issuance date), reflecting a price of NIS 0.946 per NIS 1 principal amount of the Series F Debentures. Following completion of the private placement, the aggregate outstanding par value of the Company’s Series F Debentures is NIS 210 million.

 

CEO Review for the First Quarter of 2024

 

Revenues in the first quarter of 2024 were approximately €8.2 million, compared to revenues of approximately €11.7 million in the corresponding quarter last year. Most of the decrease in revenues was due to the drop in prices in Spain, which subtracted approximately €3 million from the revenues.

 

3

 

 

Operating expenses in the first quarter of 2024 decreased by approximately €1.8 million compared to the corresponding quarter last year. Project development expenses in the first quarter of 2024 increased by approximately €0.3 million compared to the corresponding quarter last year. Project development expenses included non-recurring expenses of approximately €0.8 million. Excluding such non-recurring expenses, there was a decrease in project development expenses.

 

Activity in Spain:

 

In May 2024, the Ellomay Solar project (capacity of 28 MW) reached financial closing of project finance in the amount of €10 million for 16 years at an annual interest rate, fixed through an interest rate swap deal, of approximately 3%. After receiving the financing, the majority of the equity invested in the project was returned.

 

In the first quarter of 2024, the trend of a strong decrease in electricity prices in Europe continued, with the exception of Italy where prices remained stable. The decrease in electricity prices in Spain was approximately 70% compared to the corresponding quarter in 2023. The most significant decrease was in March 2024, in which prices decreased by approximately 90% compared to the corresponding quarter in 2023. The main reasons for the decrease in prices in Spain during the first quarter are the relatively warm winter by 6 to 8 degrees (Celsius) above average on the one hand and substantial rainfall that caused a sharp increase in hydroelectric power generation on the other hand, when in March alone the power generation from hydro sources jumped from 2000 GW in the corresponding month in 2023 to 4700 GW. The high output of hydroelectricity also caused a corresponding decrease in the prices of green certificates. A return to normative prices was recorded only in June 2024. In the Company’s estimation, this is an unusual event that affected the entire electricity sector in Europe.

 

Despite the significant drop in electricity prices in Spain, the Company’s revenues from the sale of electricity in Spain for the first quarter of 2024 did not decrease at the same rate, and stood at approximately €4.2 million, compared to revenues of approximately €7.2 million in the corresponding quarter last year. The main reason for the significant drop in electricity prices in Spain not fully impacting the Company’s revenues is that most of the electricity the Company sells in Spain is under a long-term PPA.

 

Activity of Dorad:

 

In the first quarter of 2024, the Dorad power plant recorded an increase in profit, with net profit of approximately NIS 65.6 million, an increase of approximately NIS 11.7 million compared to the corresponding quarter last year. The Dorad power station received the approval of the National Infrastructures Committee and a positive connection survey to increase the capacity by an additional 650 MW. In addition, as of July 1, 2024, the power plant will participate in the system manager’s supply tenders.

 

Activity in the USA:

 

In the USA, the development and construction activities of solar projects are progressing at a rapid pace and the construction of the first four projects, with a total capacity of approximately 49 MW, began in early 2024. Completion of construction and connection to the grid of two projects (in an aggregate capacity of approximately 27 MW) is expected by the end of 2024 and of the other two projects (in an aggregate capacity of approximately 22 MW) is expected in early 2025. Additional projects with an aggregate capacity of approximately 30-40 MW intended for construction in 2025 are under development.

 

4

 

 

Activity in Italy:

 

In Italy, the construction of a solar project with a capacity of approximately 18 MW (ELLO 10) has begun, and its construction is expected to be completed in September 2024, this is in addition to solar projects with a capacity of 20 MW whose construction has been completed. Of the 20 MW whose construction has been completed, 10 MW were connected to the grid in the first quarter of 2024 and another 10 MW are expected to be connected soon. Therefore, the increase in income from the sale of electricity in Italy will be reflected mainly in the second half of 2024. The construction prices of solar projects in Italy are declining from record levels of approximately €900 thousand per MW to approximately €675 thousand as of today, and the trend may continue. The Company is negotiating with the contractor for construction agreements adjusted to the new market prices. In addition to the 20 MW built and the 18 MW under construction, the Company has 467 MW of solar projects under development, of which 165 MW are ready for construction and 302 MW are in very advanced stages.

 

New legislation in Italy prohibits the establishment of new projects on agricultural land. This prohibition increases the value of the Company’s portfolio, which is not located on agricultural land. The Company estimates that new possibilities are emerging for obtaining a PPA in Italy, therefore it is expected that project financing will be possible more easily and at lower costs. Considering these developments, and the decrease in construction costs, the Company believes that its decision to slow down the pace of construction commencements to meet lower construction and financing costs was correct. Electricity prices in Italy maintain a stable level. Italy is the only country in Europe where no negative electricity prices were recorded. The main reason is local gas-based electricity generation, and no change is expected in the short and medium term.

 

Activity in Israel:

 

The Manara Cliff Pumped Storage Project (Company’s share is 83.34%): A project with a capacity of 156 MW, which is in advanced construction stages. The Iron Swords War, which commenced on October 7, 2023, stopped the construction work on the project. The project has protection from the state for damages and losses due to the war within the framework of the tariff regulation (covenants that support financing). The project was expected to reach commercial operation during the first half of 2027 and the continuation of the Iron Swords war will cause a delay in the date of activation. The Israeli Electricity Authority currently approved a postponement of ten months of the dates for the project. The Company and its partner in the project, Ampa, invested the equity required for the project (other than linkage differences), and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.

 

Development of Solar licenses combined with storage:

 

1.The Komemiyut and Qelahim Projects: each intended for 21 solar MW and 50 MW / hour batteries. The sale of electricity will be conducted through a private supplier. Commencement of construction is planned for the first quarter of 2025.

 

The Company waived the rights it won in a solar / battery tender process in connection with these projects and therefore paid a forfeiture of guarantee in the amount of NIS 1.8 million and is in advanced negotiations with a local supplier for the execution of a long-term PPA.

 

5

 

 

2.The Talmei Yosef Project: intended for 10 solar MW and 22 MW / hour batteries. The request for zoning approval was approved in the fourth quarter of 2023.

 

3.The Talmei Yosef Storage Project in Batteries: there is a zoning approval for approximately 400 MW / hour. The project is designed for the regulation of high voltage storage.

 

The Company also has approximately 46 solar MW under preliminary planning stages.

 

Activity in the Netherlands:

 

During the first quarter of 2024, the operational improvement in the Company’s biogas plants continued and high production levels were maintained. In addition, significant progress was made in the process of obtaining the licenses to increase production by about 50% in the three plants. Increasing production will require only small investments and is expected to increase income and EBITDA. The establishment of the new government in the Netherlands enables the continuation of the legislative process mandating the obligation to mix green gas with fossil gas and the conclusion of the legislative process is expected soon. This legislation is expected to have a positive effect on the prices of green gas and the price of the accompanying green certificates.

 

Use of Non-IFRS Financial Measures

 

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 17 of this press release.

 

6

 

 

About Ellomay Capital Ltd.

 

Ellomay is an Israeli based company whose shares are listed on the NYSE American and the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

 

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

 

Approximately 335.9 MW of photovoltaic power plants in Spain (including a 300 MW photovoltaic plant in owned by Talasol, which is 51% owned by the Company) and approximately 9.95 MW of photovoltaic power plants in Italy;
   
9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel’s total current electricity consumption;
   
Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;
   
83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
   
A photovoltaic plant with installed capacity of approximately 10 MW in the Lazio Region, Italy that is ready for connection to the grid;
   
Ellomay Solar Italy Ten SRL that is construction a photovoltaic plant (18 MW) in Italy;
   
Ellomay Solar Italy Four SRL (15.06 MW), Ellomay Solar Italy Five SRL (87.2 MW), Ellomay Solar Italy Seven SRL (54.77 MW), Ellomay Solar Italy Nine SRL (8 MW) and Ellomay Solar Italy Fifteen SRL (10 MW) that are developing photovoltaic projects in Italy that have reached “ready to build” status; and
   
Fairfield Solar Project, LLC (13.44 MW), Malakoff Solar I, LLC (6.96 MW) and Malakoff Solar II, LLC (6.96 MW), that are constructing photovoltaic plants and Mexia Solar I, LLC (5.6 MW), Mexia Solar II, LLC (5.6 MW), and Talco Solar, LLC (10.3 MW), that are developing photovoltaic projects that have reached “ready to build” status, all in the Dallas Metropolitan area, Texas.

 

For more information about Ellomay, visit http://www.ellomay.com.

 

7

 

 

Information Relating to Forward-Looking Statements

 

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, continued war and hostilities in Israel and Gaza, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Contact:

 

Kalia Rubenbach (Weintraub)

CFO

Tel: +972 (3) 797-1111

Email: hilai@ellomay.com

 

8

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position

 

 

    March 31,     December 31,     March 31,  
    2024     2023     2024  
    Unaudited     Audited     Unaudited  
    € in thousands     Convenience Translation into US$ in thousands*  
Assets                  
Current assets:                  
Cash and cash equivalents     82,722       51,127       89,421  
Short term deposits     1,045       997       1,130  
Restricted cash     729       810       788  
Intangible asset from green certificates     436       553       471  
Trade and other receivables     12,229       11,717       13,219  
Derivatives asset short-term     1,403       275       1,517  
Assets of disposal groups classified as held for sale     27,959       28,297       30,223  
      126,523       93,776       136,769  
Non-current assets                        
Investment in equity accounted investee     33,354       31,772       36,055  
Advances on account of investments     898       898       971  
Fixed assets     421,149       407,982       455,255  
Right-of-use asset     31,738       30,967       34,308  
Restricted cash and deposits     16,343       17,386       17,667  
Deferred tax     5,559       8,677       6,009  
Long term receivables     11,164       10,446       12,068  
Derivatives     20,082       10,948       21,708  
      540,287       519,076       584,041  
                         
Total assets     666,810       612,852       720,810  
                         
Liabilities and Equity                        
Current liabilities                        
Current maturities of long-term bank loans     9,710       9,784       10,496  
Current maturities of long-term loans     5,000       5,000       5,405  
Current maturities of debentures     34,478       35,200       37,270  
Trade payables     9,159       5,249       9,900  
Other payables     14,357       10,859       15,520  
Current maturities of derivatives     -       4,643       -  
Current maturities of lease liabilities     741       700       801  
Liabilities of disposal groups classified as held for sale     17,409       17,142       18,819  
      90,854       88,577       98,211  
Non-current liabilities                        
Long-term lease liabilities     24,488       23,680       26,471  
Long-term bank loans     238,999       237,781       258,354  
Other long-term loans     28,618       29,373       30,936  
Debentures     144,633       104,887       156,346  
Deferred tax     2,588       2,516       2,798  
Other long-term liabilities     4,379       939       4,734  
      443,705       399,176       479,639  
Total liabilities     534,559       487,753       577,850  
Equity                        
Share capital     25,613       25,613       27,687  
Share premium     86,189       86,159       93,169  
Treasury shares     (1,736 )     (1,736 )     (1,877 )
Transaction reserve with non-controlling Interests     5,697       5,697       6,158  
Reserves     10,955       4,299       11,842  
Accumulated deficit     (8,650 )     (5,037 )     (9,351 )
Total equity attributed to shareholders of the Company     118,068       114,995       127,628  
Non-Controlling Interest     14,183       10,104       15,332  
Total equity     132,251       125,099       142,960  
Total liabilities and equity     666,810       612,852       720,810  

 

*Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)

9

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss)

 

 

      For the three months ended
March 31,
      For the
year ended
December 31,
      For the
three months ended
March 31,
 
      2024       **2023       2023       2024  
      Unaudited       Audited       Unaudited  
      € in thousands (except per share data)       Convenience Translation into US$*  
                                 
Revenues     8,243       11,733       48,834       8,911  
Operating expenses     (4,563 )     (6,368 )     (22,861 )     (4,933 )
Depreciation and amortization expenses     (4,055 )     (3,995 )     (16,012 )     (4,383 )
Gross profit (loss)     (375 )     1,370       9,961       (405 )
                                 
Project development costs     (1,415 )     (1,164 )     (4,465 )     (1,530 )
General and administrative expenses     (1,620 )     (1,433 )     (5,283 )     (1,751 )
Share of profits of equity accounted investee     1,286       1,178       4,320       1,390  
Operating profit (loss)     (2,124 )     (49 )     4,533       (2,296 )
                                 
Financing income     631       4,747       8,747       682  
Financing income in connection with derivatives and warrants, net     536       86       251       579  
Financing expenses in connection with projects finance     (1,501 )     (1,544 )     (6,077 )     (1,623 )
Financing expenses in connection with debentures     (1,711 )     (828 )     (3,876 )     (1,850 )
Interest expenses on minority shareholder loan     (554 )     (465 )     (2,014 )     (599 )
Other financing expenses     (713 )     (267 )     (588 )     (771 )
Financing income (expenses), net     (3,312 )     1,729       (3,557 )     (3,582 )
Profit (loss) before taxes on income     (5,436 )     1,680       976       (5,878 )
Tax benefit     828       1,352       1,436       895  
Profit (loss) from continuing operations     (4,608 )     3,032       2,412       (4,983 )
Profit (loss) from discontinued operation (net of tax)     (312 )     242       (1,787 )     (337 )
Profit (loss) for the period     (4,920 )     3,274       625       (5,320 )
Profit (loss) attributable to:                                
Owners of the Company     (3,613 )     4,081       2,219       (3,906 )
Non-controlling interests     (1,307 )     (807 )     (1,594 )     (1,414 )
Profit (loss) for the period     (4,920 )     3,274       625       (5,320 )
                                 
Other comprehensive income items                                
That after initial recognition in comprehensive income were or will be transferred to profit or loss:                                
Foreign currency translation differences for foreign operations     1,124       (5,550 )     (7,949 )     1,215  
Effective portion of change in fair value of cash flow hedges     10,461       34,405       39,431       11,308  
Net change in fair value of cash flow hedges transferred to profit or loss     457       (2,231 )     9,794       494  
Total other comprehensive income     12,042       26,624       41,276       13,017  
                                 
Total other comprehensive income attributable to:                                
Owners of the Company     6,656       11,015       16,931       7,195  
Non-controlling interests     5,386       15,609       24,345       5,822  
Total other comprehensive income     12,042       26,624       41,276       13,017  
Total comprehensive income for the period     7,122       29,898       41,901       7,697  
                                 
Total comprehensive income for the period attributable to:                                
Owners of the Company     3,043       15,096       19,150       3,289  
Non-controlling interests     4,079       14,802       22,751       4,408  
Total comprehensive income for the period     7,122       29,898       41,901       7,697  

 

*Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)
**The results of the Talmei Yosef solar plant have been reclassified as a discontinued operation and the results for these periods have been adjusted accordingly.

 

10

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) (con’t)

 

 

      For the three months ended
March 31,
      For the
year ended
December 31,
      For the
three months ended
March 31,
 
      2024       2023       2023       2024  
      Unaudited       Audited       Unaudited  
      € in thousands (except per share data)       Convenience Translation into US$*  
                         
Basic profit (loss) per share     (0.28 )     0.27       0.17       (0.31 )
Diluted profit (loss) per share     (0.28 )     0.27       0.17       (0.31 )
                                 
Basic profit (loss) per share continuing operations     (0.31 )     0.25       0.31       (0.34 )
Diluted profit (loss) per share continuing operations     (0.31 )     0.25       0.31       (0.34 )
                                 
Basic profit (loss) per share discontinued operation     (0.02 )     0.02       (0.14 )     (0.02 )
Diluted profit (loss) per share discontinued operation     (0.02 )     0.02       (0.14 )     (0.02 )

 

*Convenience translation into US$ (exchange rate as at March 31, 2023: euro 1 = US$ 1.081)

 

11

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity

  

                Attributable to shareholders of the Company          
    Share capital     Share premium     Accumulated
Deficit
    Treasury
shares
    Translation
reserve
from
foreign
operations
    Hedging
Reserve
    Interests
Transaction
reserve with
non-controlling
Interests
    Total     Non- controlling Interests     Total Equity  
    € in thousands  
For the three months ended March 31, 2024 (unaudited):                                                            
Balance as at January 1, 2024     25,613       86,159       (5,037 )     (1,736 )     385       3,914       5,697       114,995       10,104       125,099  
Loss for the period     -       -       (3,613 )     -       -       -       -       (3,613 )     (1,307 )     (4,920 )
Other comprehensive income for the period     -       -       -       -       1,088       5,568       -       6,656       5,386       12,042  
Total comprehensive income for the period     -       -       (3,613 )     -       1,088       5,568       -       3,043       4,079       7,122  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments     -       30       -       -       -       -       -       30       -       30  
Balance as at March 31, 2024     25,613       86,189       (8,650 )     (1,736 )     1,473       9,482       5,697       118,068       14,183       132,251  
                                                                                 
For the three months                                                                                
ended March 31, 2023 (unaudited):                                                                                
Balance as at January 1, 2023     25,613       86,038       (7,256 )     (1,736 )     7,970       (20,602 )     5,697       95,724       (12,647 )     83,077  
Profit for the period     -       -       4,081       -       -       -       -       4,081       (807 )     3,274  
Other comprehensive income for the period     -       -       -       -       (5,292 )     16,307       -       11,015       15,609       26,624  
Total comprehensive income for the period     -       -       4,081       -       (5,292 )     16,307       -       15,096       14,802       29,898  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments     -       31       -       -       -       -       -       31       -       31  
Balance as at March 31, 2023     25,613       86,069       (3,175 )     (1,736 )     2,678       (4,295 )     5,697       110,851       2,155       113,006  

  

12

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (cont’d)

 

           Attributable to shareholders of the Company       
   Share
capital
   Share
premium
   Accumulated
Deficit
   Treasury
shares
   Translation
reserve
from
foreign
operations
   Hedging
Reserve
   Interests
Transaction
reserve with
non-controlling
Interests
   Total   Non-
controlling
Interests
   Total
Equity
 
   € in thousands 
For the year ended December 31, 2023 (audited):                                        
Balance as at January 1, 2023   25,613    86,038    (7,256)   (1,736)   7,970    (20,602)   5,697    95,724    (12,647)   83,077 
Profit for the year   -    -    2,219    -    -    -    -    2,219    (1,594)   625 
Other comprehensive income for the year   -    -    -    -    (7,585)   24,516    -    16,931    24,345    41,276 
Total comprehensive income for the year   -    -    2,219    -    (7,585)   24,516    -    19,150    22,751    41,901 
Transactions with owners of the Company, recognized directly in equity:                                                  
Share-based payments   -    121    -    -    -    -    -    121    -    121 
Balance as at December 31, 2023   25,613    86,159    (5,037)   (1,736)   385    3,914    5,697    114,995    10,104    125,099 

 

13

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (cont’d)

 

           Attributable to shareholders of the Company       
   Share
capital
   Share
premium
   Accumulated
Deficit
   Treasury
shares
   Translation
reserve
from
foreign
operations
   Hedging
Reserve
   Interests
Transaction
reserve with
non-controlling
Interests
   Total   Non-
controlling
Interests
   Total
Equity
 
   Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081) 
For the three months ended March 31, 2024 (unaudited):                                        
Balance as at January 1, 2024   27,687    93,137    (5,445)   (1,877)   416    4,231    6,158    124,307    10,924    135,231 
Loss for the period   -    -    (3,906)   -    -    -    -    (3,906)   (1,414)   (5,320)
Other comprehensive income for the period   -    -    -    -    1,176    6,019    -    7,195    5,822    13,017 
Total comprehensive income for the period   -    -    (3,906)   -    1,176    6,019    -    3,289    4,408    7,697 
Transactions with owners of the Company, recognized directly in equity:                                                  
Share-based payments   -    32    -    -    -    -    -    32    -    32 
Balance as at March 31, 2024   27,687    93,169    (9,351)   (1,877)   1,592    10,250    6,158    127,628    15,332    142,960 

 

14

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Cash Flow

 

   For the three months
ended March 31,
   For the year ended December 31,   For the three months ended March 31, 
   2024   2023   2023   2024 
   Unaudited   Audited   Unaudited 
   € in thousands   Convenience Translation into US$* 
Cash flows from operating activities                
Profit (loss) for the period   (4,920)   3,274    625    (5,320)
Adjustments for:                    
Financing expenses (income), net   3,167    (2,023)   3,034    3,425 
Impairment losses on assets of disposal groups classified as held-for-sale   601    -    2,565    650 
Depreciation and amortization   4,084    4,115    16,473    4,414 
Share-based payment transactions   30    31    121    32 
Share of profit of equity accounted investees   (1,286)   (1,178)   (4,320)   (1,390)
Payment of interest on loan from an equity accounted investee   -    -    1,501    - 
Change in trade receivables and other receivables   (2,342)   (1,373)   (302)   (2,532)
Change in other assets   -    (120)   (681)   - 
Change in receivables from concessions project   315    257    1,778    341 
Change in trade payables   (68)   (876)   (45)   (74)
Change in other payables   2,796    1,417    (2,235)   3,022 
Income tax benefit   (805)   (1,256)   (1,852)   (870)
Income taxes refund (paid)   564    -    (912)   610 
Interest received   907    493    2,936    980 
Interest paid   (1,892)   (923)   (10,082)   (2,045)
    6,071    (1,436)   7,979    6,563 
Net cash from operating activities   1,151    1,838    8,604    1,243 
                     
Cash flows from investing activities                    
Acquisition of fixed assets   (9,020)   (13,331)   (58,848)   (9,750)
Interest paid capitalized to fixed assets   -    -    (2,283)   - 
Repayment of loan to an equity accounted investee   -    -    1,324    - 
Loan to an equity accounted investee   -    (60)   (128)   - 
Advances on account of investments   -    (382)   (421)   - 
Proceeds from advances on account of investments   -    -    2,218    - 
Proceeds in marketable securities   -    2,837    2,837    - 
Investment in settlement of derivatives, net   14    -    -    15 
Proceed from restricted cash, net   1,153    893    840    1,246 
Investment in short-term deposits   (28)   (21,945)   (1,092)   (30)
Net cash used in investing activities   (7,881)   (31,988)   (55,553)   (8,519)
                     
Cash flows from financing activities                    
Issuance of warrants   3,735    -    -    4,037 
Cost associated with long term loans   (638)   (315)   (1,877)   (690)
Payment of principal of lease liabilities   (299)   (200)   (1,156)   (323)
Proceeds from long-term loans   380    764    32,157    411 
Repayment of long-term loans   (2,357)   (686)   (12,736)   (2,548)
Repayment of debentures   -    -    (17,763)   - 
Proceeds from issuance of debentures, net   36,450    55,808    55,808    39,402 
Net cash from financing activities   37,271    55,371    54,433    40,289 
                     
Effect of exchange rate fluctuations on cash and cash equivalents   1,667    (1,942)   (2,387)   1,804 
Increase in cash and cash equivalents   32,208    23,279    5,097    34,817 
Cash and cash equivalents at the beginning of year   51,555    46,458    46,458    55,730 
Cash from disposal groups classified as held-for-sale   (1,041)   -    (428)   (1,125)
Cash and cash equivalents at the end of the period   82,722    69,737    51,127    89,422 

 

*Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)

 

15

 

 

Ellomay Capital Ltd. and its Subsidiaries

Operating Segments

  

   Italy   Spain   USA   Netherlands   Israel   Total         
       Subsidized   28 MV                           reportable       Total 
   PV   Plants   PV   Talasol   PV   Biogas   Dorad   Manara   PV*   segments   Reconciliations   consolidated 
   For the three months ended March 31, 2024 
   € in thousands 
                                                 
Revenues   71    740    245    3,180    -    4,007    14,392    -    288    22,923    (14,680)   8,243 
Operating expenses   -    (131)   (218)   (912)   -    (3,302)   (10,290)   -    (83)   (14,936)   10,373    (4,563)
Depreciation expenses   -    (229)   (237)   (2,871)   -    (712)   (1,308)   -    (29)   (5,386)   1,331    (4,055)
Gross profit (loss)   71    380    (210)   (603)   -    (7)   2,794    -    176    2,601    (2,976)   (375)
                                                             
Adjusted gross profit (loss)   71    380    (210)   (603)   -    (7)   2,794    -    (1,454)   971    (1,346)   (375)
Project development costs                                                          (1,415)
General and administrative expenses                                                          (1,620)
Share of loss of equity accounted investee                                                          1,286 
Operating profit                                                          (2,124)
Financing income                                                          631 
Financing income in connection with derivatives and warrants, net                                                          536 
Financing expenses in connection with projects finance                                                          (1,501)
Financing expenses in connection with debentures                                                          (1,711)
Interest expenses on minority shareholder loan                                                          (554)
Other financing expenses                                                          (713)
Financing expenses, net                                                          (3,312)
Loss before taxes on income                                                          (5,436)
                                                             
Segment assets as at March 31, 2024   46,213    13,289    18,455    233,200    15,647    31,105    100,514    174,819    27,959    661,201    5,609    666,810 

 

*The results of the Talmei Yosef solar plant are presented as a discontinued operation.

 

16

 

 

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA

 

   For the three months ended
March 31,
   For the
year ended
December 31,
   For the
three months
ended March 31,
 
   2024   **2023   2023   2024 
   € in thousands   Convenience Translation into US$* 
Net profit (loss) for the period   (4,920)   3,274    625    (5,320)
Financing expenses (income), net   3,312    (1,729)   3,557    3,582 
Tax benefit   (828)   (1,352)   (1,436)   (895)
Depreciation and amortization expenses   4,055    3,995    16,012    4,383 
EBITDA   1,619    4,188    18,758    1,750 

 

*Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)
**The results of the Talmei Yosef PV Plant have been reclassified as a discontinued operation and the results for these periods have been adjusted accordingly.

 

17

 

 

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders

 

Financial Covenants

 

Pursuant to the Deeds of Trust governing the Company’s Series C, Series D, Series E and Series F Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2023, and below.

 

Net Financial Debt

 

As of March 31, 2024, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €102.5 million (consisting of approximately €300.22 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €186.33 million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), the Series D Convertible Debentures issuance (in February 2021), the Series E Secured Debentures issuance (in February 2023) and the Series F Debentures issuance (in January 2024)), net of approximately €83.8 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €300.24 million of project finance and related hedging transactions of the Company’s subsidiaries).

 

 

2The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.7 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.
3The amount of the debentures provided above includes an amount of approximately €1.6 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company’s balance sheet.
4The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).

 

18

 

 

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (con’t)

 

Information for the Company’s Series C Debenture Holders.

 

The Deed of Trust governing the Company’s Series C Debentures (as amended on June 6, 2022, the “Series C Deed of Trust”), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series C Deed of Trust) was approximately €117.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA5, was 5.5.

 

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended March 31, 2024:

 

   For the
four-quarter
period ended
March 31,
2024
 
   Unaudited 
   € in thousands 
Loss for the period   (7,569)
Financing expenses, net   8,892 
Tax benefit   (1,008)
Depreciation and amortization expenses   15,952 
Share-based payments   120 
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model   2,331 
Adjusted EBITDA as defined the Series C Deed of Trust   18,718 

 

 

5The term “Adjusted EBITDA” is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

 

19

 

 

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (con’t)

 

Information for the Company’s Series D Debenture Holders

 

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €117.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA6 was 5.5.

 

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 2024:

 

   For the
four-quarter period ended March 31, 2024
 
   Unaudited 
   € in thousands 
Loss for the period   (7,569)
Financing expenses, net   8,892 
Tax benefit   (1,008)
Depreciation and amortization expenses   15,952 
Share-based payments   120 
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model   2,331 
Adjusted EBITDA as defined the Series D Deed of Trust   18,718 

 

 

6The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

 

20

 

 

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (con’t)

 

Information for the Company’s Series E Debenture Holders

 

The Deed of Trust governing the Company’s Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series E Deed of Trust) was approximately €117.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA7 was 5.5.

 

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended March 31, 2024:

 

   For the
four-quarter period ended March 31, 2024
 
   Unaudited 
   € in thousands 
Loss for the period   (7,569)
Financing expenses, net   8,892 
Tax benefit   (1,008)
Depreciation and amortization expenses   15,952 
Share-based payments   120 
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model   2,331 
Adjusted EBITDA as defined the Series E Deed of Trust   18,718 

 

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. (“Ellomay Luzon Energy”)), which were pledged to the holders of the Company’s Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

 

As of March 31, 2024, the value of the assets pledged to the holders of the Series E Debentures in the Company’s books (unaudited) is approximately €33.4 million (approximately NIS132.7 million based on the exchange rate as of such date).

 

 
7The term “Adjusted EBITDA” is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

 

21

 

 

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (con’t)

 

Information for the Company’s Series F Debenture Holders

 

The Deed of Trust governing the Company’s Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series F Deed of Trust) was approximately €116.2 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 46.9%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA8 was 5.5.

 

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended March 31, 2024:

 

   For the
four-quarter period ended March 31, 2024
 
   Unaudited 
   € in thousands 
Loss for the period   (7,569)
Financing expenses, net   8,892 
Tax benefit   (1,008)
Depreciation and amortization expenses   15,952 
Share-based payments   120 
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model   2,331 
Adjusted EBITDA as defined the Series F Deed of Trust   18,718 

 

 

8The term “Adjusted EBITDA” is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

 

22